| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.5 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.5 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.5 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |